Modulation of stem cell differentiation by the influence of nanobiomaterials/carriers

Current Stem Cell Research and Therapy

Volumn 9, Issue 6, 2014, Pages 458-468

  Bokara, Kiran Kumar ^a   Oggu, Gopi Suresh ^a   Vidyasagar, Aditya Josyula ^a   Asthana, Amit ^a   Lee, Jong Eun ^b   Rao, Mohan Ch ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Biocompatibility; Nanobiomaterials; Stem cell differentiation; Stem cells

Indexed keywords

BIOMATERIAL; CARBON NANOFIBER; CARBON NANOTUBE; COLLAGEN TYPE 1; DIMETICONE; DNA NANOCARRIER; FIBROBLAST GROWTH FACTOR 2; HYDROXYAPATITE; LIPOSOME; MOLECULAR SCAFFOLD; NANOBIOMATERIAL; NANOCARRIER; NANOFIBER; NANOMATERIAL; NANOTUBE; NANOWIRE; PARVOVIRUS VECTOR; POLYCAPROLACTONE; POLYLACTIC ACID; RETROVIRUS VECTOR; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; SYNTHETIC DNA; UNCLASSIFIED DRUG;

ADIPOSE DERIVED STEM CELL; ADULT STEM CELL; ARTICLE; BACTERIAL ARTHRITIS; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CALCIUM PHOSPHATE CERAMIC; CELL DIFFERENTIATION; CELL HOMING; CELL PROLIFERATION; CELL RENEWAL; ELECTROSPINNING; EMBRYONIC STEM CELL; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HYDROGEL; IMMUNE RESPONSE; KNEE ARTHRITIS; NANOTECHNOLOGY; NEURAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; STEM CELL; STEM CELL EXPANSION; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION; WOUND HEALING; ANIMAL; CELL CULTURE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PHYSIOLOGY; TISSUE SCAFFOLD;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NANOSTRUCTURES; REGENERATIVE MEDICINE; TISSUE SCAFFOLDS;

EID: 84924335740     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X09666140828122903     Document Type: Article

References (137)

1. [1] Damien C, Parsons R. Bone graft and bone graft substitutes: A review of current technology and applications. J Appl Biomater 1991; 2(3): 187-208.
2. [2] Mekala NK, Baadhe RR, Parcha SR. Review on engineering bio- materials in tissue engineering application. Rec Res Sci Technol 2012; 4(12): 5-11.
3. [3] Mason C, Dunnill P. A brief definition of regenerative medicine. Regen Med 2008; 3(1): 1-5.
4. [4] Allison C, Bean D, Rocky S. Stem cells and Nanotechnology in Tissue engineering and regenerative medicine, Micro and Nanotech-nologies in Engineering Stem Cells and Tissues, First Edition, John Wiley & Sons, Inc 2013.
5. [5] Mekala NK, Baadhe RR, Potumarthi R. Mass transfer aspects of 3D cell cultures in tissue engineering. Asia-Pac J Chem Eng 2014; 9(3): 318-29.
6. [6] Thomson JA. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282 (5391): 1014-5.
7. [7] Orlando G, Wood KJ, Stratta RJ, et al. Regenerative medicine and organ transplantation: past, present, andfuture. Transplantation 2011; 91(12): 1310-7.
8. [8] Tse WT, Pendleton JD, Beyer WM, et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003; 75(3): 389-97.
9. [9] Le Blanc K, Tammik C, Rosendahl K, et al. HLA expression and immunologic properties of differentiated and undifferentiated mes-enchymal stem cells. Exp Hematol 2003; 31(10): 890-6.
10. [10] Zhao T, Zhang Z-N, Rong Z, Xu Y. Immunogenicity of induced pluripotent stem cells. Nature 2011; 474(7350): 212-5.
11. [11] Yu J, Hu K, Smuga-Otto K, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009; 324 (5928): 797-801.
12. [12] Drukker M, Katchman H, Katz G, et al. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 2006; 24(2): 221-9.
13. [13] Dutkowski P, Rougemont O, Clavien PA. Alexis Carrel: Genius, innovator andideologist. Am J Transplant 2008; 8(10): 1998-2003.
14. [14] Jia F, Wilson KD, Sun Ning, et al. A nonviral minicircle vector for deriving human iPS cells. Nat Methods 2010; 7(3): 197-9.
15. [15] Zhou H, Wu S, Joo JY, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009; 4(5): 381-4.
16. [16] Kim D, Kim CH, Moon JI, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009; 4(6): 472-6.
17. [17] Ben-David U, Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer 2011; 11: 268-77.
18. [18] Mali P, Cheng L. Human cell engineering: cellular reprogramming and genome editing. Stem Cells 2012; 30 (1): 75-81.
19. [19] Kent DG, Copley MR, Benz , et al. Prospective isolation and molecular characterization of hematopoietic stem cells with durable self-renewal potential. Blood 2009; 113(25): 6342-50.
20. [20] Veronique Lecault, Michael VanInsberghe, Sanja Sekulovic, et al. High throughput analysis of single hematopoietic stem cell proliferation in microfluidic cell culture arrays. Nat Methods 2011; 8: 581-6.
21. [21] Mironov, V, Richard P., Visconti R., Markwald, D et al. Organ printing: tissue spheroids as building blocks. Biomaterials 2009; 30(12): 2164-74.
22. [22] Wang, X, Yan YN, Zhang RJ. Recent trends and challenges in complex organ manufacturing. Tissue Eng Part B: Rev 2010; 16(2): 189-97.
23. [23] Hutmacher DW. Scaffold design and fabrication technologies for engineering tissues: state of the art and future perspectives. J Bio-mater 2001; 12: 107-24.
24. [24] Huebsch N, Arany PR, Mao AS, et al. Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate. Nat Mater 2010; 9(6): 518-26.
25. [25] Mekala NK, Baadhe RR, Parcha SR. Study on Osteoblast like Behavior of Umbilical Cord Blood Cells on Various Combinations of PLGA Scaffolds Prepared by Salt Fusion. Curr Stem Cell Res Ther 2013; 8(3): 253-9.
26. [26] Winer, Laidmäe I, Sawyer ES, et al. Non-linear elasticity of contractile cells to communicate local position and orientation. PLoS ONE 2009; 4(7): e6382.
27. [27] Sachlos E and Czernuszka J. Making tissue engineering scaffolds work. Review on the application of solid freeform fabrication technology to the production of tissue engineering scaffolds. Eur Cells Mater 2003; 5: 29-39.
28. [28] Nigam SK, Bertrand Guillotin, Fabien Guillemot, et al. Organo-genesis forum lecture. Organogenesis 2008; 4: 137-43.
29. [29] Ohyabu Y, Kaul Z, Yoshioka T, et al. Stable and nondisruptive in vitro/in vivo labeling of mesenchymal stem cells by internalizing quantum dots. Hum Gene Ther 2009; 20(3): 217-24.
30. [30] Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells mouse embryos. Nature 1981; 292: 154-6.
31. [31] Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 1981; 78: 7634-8.
32. [32] Thomson J, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-7.
33. [33] Giordano A, Galderisi U, Marino IR. An update on clinical trials with mesenchymal stem cells. J Cell Physiol 2007; 211(1): 27-35.
34. [34] Matsumoto D, Sato K, Gonda K, et al. Cell-assisted lipotransfer: Supportive use of human adipose-derived cells for soft tissue augmentation with lipoinjection, Tissue Eng 2006; 12(12): 3375–3382.
35. [35] Yoshimura K, Sato K, Aoi N, Kurita M, Hirohi T, Harii K. Cell assisted lipotransfer for cosmetic breast augmentation: Supportive use of adipose-derived stem/stromal cells. Aesthetic Plast Surg 2008a, 32(1): 48-55.
36. [36] Wakitani S, Imoto K, Yamamoto T, et al. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage 2002; 10(3): 199-206.
37. [37] Wakitani S, Mitsuoka, T, Nakamura N, et al. Autologous bone marrow stromal cell transplantation for repair of full thickness articular cartilage defects in human patellae: Two case reports. Cell Transplant 2004; 13(5): 595-600.
38. [38] Adachi N, Ochi M, Deie M, et al. Transplant of mesenchymal stem cells and hydroxyapatite ceramics to treat severe osteochondral damage after septic arthritis of the knee. J Rheumatol 2005; 32(8): 1615-8.
39. [39] Morishita T, Honoki K, Ohgushi H, Kotobuki N, Matsushima A, Takakura Y. Tissue engineering approach to the treatment of bone tumors: Three cases of cultured bone grafts derived from patients’ mesenchymal stem cells. Artif Organs 2006; 30(2): 115-8.
40. [40] Vacanti CA, Bonassar LJ, Vacanti MP, Shufflebarger J. Replacement of an avulsed phalanx with tissue-engineered bone. N Engl J Med 2001; 344(20): 1511-4.
41. [41] Shayesteh, YS, Khojasteh, A, Soleimani, M, et al. Sinus augmentation using human mesenchymal stem cells loaded into a beta-tricalcium phosphate/hydroxyapatite scaffold. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 106(2): 203-9.
42. [42] Marchetto, MC, WinnerB. & Gage FH. Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases. Hum Mol Genet 2010; 19: 71-6.
43. [43] Elloumi-Hannachi, I, Elloumi-Hannachi, Yamato M, et al. Cell sheet engineering: a unique nanotechnology for scaffold-free tissue reconstruction with clinical applications in regenerative medicine. J Intern Med 2010; 267(1): 54-70.
44. [44] Lheureux N, Dusserre N, Konig G, et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 2006; 12: 361-5.
45. [45] McAllister TN, Marcin Maruszewski MD, Sergio A, Garrido , et al. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 2009; 373(9673): 1440-6.
46. [46] McGuigan AP and Sefton, MV. Vascularized organoid engineered by modular assembly enables blood perfusion. Proc Natl Acad Sci USA 2006; 103(31): 11461-6.
47. [47] Mekala NK, Baadhe RR, Parcha SR, Prameela DY. Osteoblast Differentiation of Umbilical Cord Blood-Derived Mesenchymal Stem Cells and Enhanced Cell Adhesion by Fibronectin. Tissue Eng Regen Med 2012; 9(5): 250-5.
48. [48] Fernandez JG, Khademhosseini, A. Micro-masonry: construction of 3D structures by microscale self-assembly. Adv Mater 2010; 22(23): 2538-41.
49. [49] Du Y, Edward Lo, Ali Khademhosseini, et al. Directed assembly of cell-laden microgels for fabrication of 3D tissue constructs. Proc Natl Acad Sci USA 2008; 105(28): 9522-7.
50. [50] Wang X, Yan Y, Zhang R, et al. Recent trends and challenges in complex organ manufacturing. Tissue Eng Part B: Rev 2010; 16(2): 189-97.
51. [51] Fedorovich NE, Swennen I, Girones J, et al. Evaluation of pho-tocrosslinked lutrol hydrogel for tissue printing applications. Bio-macromolecules 2009; 10(7): 1689-96.
52. [52] Iwami K, Noda T, Ishida K, Morishima K, Nakamura M, Umeda N. Bio rapid prototyping by extruding/aspirating/refilling thermo reversible hydrogel. Biofabrication 2010; 2(1): 014108.
53. [53] Kelm JM, Fussenegger M. Microscale tissue engineering using gravity-enforced cell assembly. Trends Biotechnol 2004; 22(4): 195–202
54. [54] Foty R, Pfleger CM, Forgacs G, et al. Surface tensions of embryonic tissues predict their mutual envelopment behavior. Develop-ment11996; 122(5): 1611-20.
55. [55] Taff BM, Voldman J. A scalable addressable positive dielectropho-retic cell-sorting array. Anal Chem 2005; 77(24): 7976-83.
56. [56] Nahmias Y, Odde DJ. Micropatterning of living cells by laser-guided direct writing: application to fabrication of hepatic endothe-lial sinusoid-like structures. Nat Protocols 2006; 1(5): 2288-96.
57. [57] Boland T, Xu T, Damon B, et al. Application of inkjet printing to tissue engineering. Biotechnol J 2006; 1(9): 910-7.
58. [58] Saunders RE, Gough JE, Derby B. Delivery of human fibroblast cells by piezoelectric drop-on-demand inkjet printing. Biomaterials 2008; 29(2): 193-203.
59. [59] Nakamura M, Nishiyama Y, Henmi C, et al. Ink jet three-dimensional digital fabrication for biological tissue manufacturing: analysis of alginate microgel beads produced by ink jet droplets for three dimensional tissue fabrication. J Imaging Sci Technol 2008; 52(6): 060201-7.
60. [60] Cui X, Boland T. Human microvasculature fabrication using thermal inkjet printing technology. Biomaterials 2009; 30(31): 6221-7.
61. [61] Nair K, Gandhi M, Khalil S, et al. Characterization of cell viability during bioprinting processes. Biotechnol J 2009; 4(8): 1168-77.
62. [62] Xu T, Jin J, Gregory C, Hickman JJ, Boland T. Inkjet printing of viable mammalian cells. Biomaterials 2005; 26(1): 93-9.
63. [63] Barron JA, Bradley RR, Kim H, et al. Application of laser printing to mammalian cells. Thin Solid Films 2004; (453–454): 383-7.
64. [64] Barron JA, Wu P, Ladouceur HD, Ringeisen BR. Biological laser printing: a novel technique for creating heterogeneous 3-dimensional cell patterns. Biomed. Micro devices 2004; 6(2): 139-47.
65. [65] Hopp B, Smausz T, Kresz N, et al. Survival and proliferative ability of various living cell types after laser-induced forward transfer. Tissue Eng 2005; 11(11): 1817-23.
66. [66] Gruene M, Deiwick A, Koch L, et al. Laser printing of stem cells for biofabrication of scaffold free autologous grafts. Tissue Eng. Part C8 2010: 100830145320029.
67. [67] Othon, CM, Wu X, Anders JJ, et al. Single-cell printing to form three-dimensional lines of olfactory sheathing cells. Biomed Mater 2008; 3(3): 034101.
68. [68] Yang Y, Xia T, Zhi W, et al. Promotion of skin regeneration in diabetic rats by electrospun core-sheath fibers loaded with basic fi-broblast growth factor. Biomaterials 2011; 32(18): 4243-54.
69. [69] Janmey PA, Winer JP, Weisel JW. Fibrin gels and their clinical and bioengineering applications. J Soc Interface 2009; 6(30): 1-10.
70. [70] Mekala NK, Baadhe RR, Parcha SR, Prameela DY. Enhanced Proliferation and Osteogenic Differentiation of Human Umbilical Cord Blood Stem Cells by L-Ascorbic Acid, In vitro. Curr Stem Cell Res Ther 2013; 8(2): 156-62.
71. [71] Ahmed TA, Dare EV, Hincke M. Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng Part B Rev 2008; 14(2): 199-215.
72. [72] Ehrbar M, Metters A, Zammaretti P, et al. Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. J Control Release 2005; 101(1-3): 93-109.
73. [73] Bhang SH, Jeon O, Choi CY, Kwon YH, Kim BS. Controlled release of nerve growth factor from fibrin gel. J Biomed Mater Res 2007; 80(4): 998-1002.
74. [74] Guilak F, Cohen DM, Estes BT, et al. Control of stem cell fate by physical interactions with the extracellular matrix. Cell Stem Cell 2009; 5(1): 17-26.
75. [75] Huebsch N, Arany PR, Mao AS, et al. Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate. Nat Mater 2010; 9(6): 518-26.
76. [76] Trappmann B, Gautrot JE, Connelly JT, et al. Extracellular-matrix tethering regulates stem-cell fate. Nat Mater 2012; 11(7): 642-9.
77. [77] HJ , Boontheekul T, Mooney DJ. Quantifying the relation between adhesion ligand- receptor bond formation and cell phenotype. Proc Natl Acad Sci USA 2006; 103(49): 18534-9.
78. [78] Chu C, Schmidt JJ, Carnes K, et al. Three-dimensional synthetic niche components to control germ cell proliferation. Tissue Eng Part A 2009; 15(2): 255-62.
79. [79] Yim EK, Pang SW, Leong KW. Synthetic nanostructures inducing differentiation of human mesenchymal stem cells into neuronal lineage. Exp Cell Res 2007; 313(9): 1820-9.
80. [80] McMurray RJ, Gadegaard N, Tsimbouri PM, et al. Nanoscale surfaces for the long-term maintenance of mesenchymal stem cell phenotype and multipotency. Nat Mater 2011; 10(8): 637-44.
81. [81] Lee MR, Kwon KW, Jung H, et al. Direct differentiation of human embryonic stem cells into selective neurons on nanoscale ridge/groove pattern arrays. Biomaterials 2010; 31(15): 4360-6.
82. [82] Chen W, Villa-Diaz LG, Sun Y, et al. Nanotopography influences adhesion, spreading, and self-renewal of human embryonic stem cells. ACS Nano 2012; 6(5): 4094-103.
83. [83] Pan F, Zhang M, Wu G, et al. Topographic effect on human induced pluripotent stem cells differentiation towards neuronal lineage. Biomaterials 2013; 34(33): 8131-9.
84. [84] Oh S, Brammer KS, Li YS, et al. Stem cell fate dictated solely by altered nanotube dimension. Proc Natl Acad Sci USA 2009; 106(7): 2130-5.
85. [85] Park J, Bauer S, Von Der Mark K, Schmuki P. Nanosize and vitality: TiO2 nanotube diameter directs cell fate. Nano Lett 2007; 7(6): 1686-91.
86. [86] Park J, Bauer S, Schlegel KA, et al. TiO2 nanotube surfaces: 15 nm-an optimal length scale of surface topography for cell adhesion and differentiation. Small 2009; 5(6): 666-71.
87. [87] Dalby MJ, Gadegaard N, Tare R, et al. The control of human mes-enchymal cell differentiation using nanoscale symmetry and disorder. Nat Mater 2007; 6(12): 997-1003.
88. [88] Dalby MJ, Andar A, Nag A, et al. Genomic expression of mesen-chymal stem cells to altered nanoscale topographies. J R Soc Interface 2008; 5(26): 1055-65.
89. [89] Silva GA, Czeisler C, Niece KL, et al. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science 2004; 303(5662): 1352-5.
90. [90] Hosseinkhani H, Hosseinkhani M, Tian F, et al. Osteogenic differentiation of mesenchymal stem cells in self-assembled peptide am-phiphile nanofibers. Biomaterials 2006; 27(22): 4079-86.
91. [91] Zhang S, Holmes T, Lockshin C, Rich A. Spontaneous assembly of a self-complementary oligopeptide to form a stable macroscopic membrane. Proc Natl Acad Sci USA 1993; 90(8): 3334-8.
92. [92] Leung GK, Wang YC, Wu W. Peptide nanofiber scaffold for brain tissue reconstruction. Methods Enzymol 2012; 508: 177-90
93. [93] Ellis-Behnke RG, Liang YX, You SW, et al. Schneider GE. Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc Natl Acad Sci USA 2006; 103(13): 5054-9
94. [94] Garreta E, Genove E, Borros S, Semino CE. Osteogenic differentiation of mouse embryonic stem cells and mouse embryonic fibro-blasts in a three- dimensional self-assembling peptide scaffold. Tissue Eng 2006; 12(8): 2215-27.
95. [95] Gelain F, Bottai D, Vescovi A, Zhang S. Designer self-assembling peptide nanofiber scaffolds for adult mouse neural stem cell 3-dimensional cultures. PLoS One 2006; 1: e119.
96. [96] Guo J, Su H, Zeng Y, et al. Reknitting the injured spinal cord by self-assembling peptide nano- fiber scaffold. Nanomedicine 2007; 3(4): 311-21.
97. [97] Zhang S, Holmes TC, DiPersio CM, et al. Self-complementary oligopeptide matrices support mammalian cell attachment. Bioma-terials 1995; 16(18): 1385-93.
98. [98] Dalby MJ, Gadegaard N, Tare R, et al. The control of human mes-enchymal cell differentiation using nanoscale symmetry and disorder. Nat Mater 2007; 6: 997-1003.
99. [99] Blattler T, Huwiler C, Ochsner M, et al. Grandin: Nanopatterns with biological functions. J Nanosci Nanotechnol 2006; 6: 2237-2264.
100. [100] Tse KH, Sun M, Mantovani C, et al. Biomedical application of polymeric nanofibers, J Biomed Mater Res 2010; Part A 95A:701.
101. [101] Hicok KC, Du Laney TV, Zhou YS. et al. Human adipose derived adult stem cells produce osteoid in vivo. Tissue Engineering 2004; 10 (3-4): 371-80.
102. [102] Levi B, James AW, Nelson ER, et al. Human adipose derived stromal cells heal critical size mouse calvarial defects. PLoS One 2010; 5(6): e11177.
103. [103] Duttenhoefer F, Lara de Freitas R, Meury T, et al. 3D Scaffolds co-seeded with human endothelial progenitor and mesenchymal stem cells: evidence of prevascularisation within 7, European Cells and Materials 2000; 262013: 49-65.
104. [104] Singh S, Wu BM, Dunn JC. Accelerating Vascularization in Poly-caprolactone Scaffolds by Endothelial Progenitor Cells, Tissue Engineering 2011: Part A 17: 13-14.
105. [105] Chang NJ, Lam CF, Lin CC, et al. Transplantation of autologous endothelial progenitor cells in porous PLGA scaffolds create a mi-croenvironment for the regeneration of hyaline cartilage in rabbits. Osteoarthritis Cartilage 2013; 21: 1613-22.
106. [106] Recknor JB, Sakaguchi DS, Mallapragada SK. Directed growth and selective differentiation of neural progenitor cells on micropat-terned polymer substrates. Biomaterials 2006; 27: 4098-108.
107. [107] Yang F, Murugan R, Wang S, Ramakrishna S. Electrospinning of nano/micro scale poly- L-lactic acid aligned fibers and their potential in neural tissue engineering. Biomaterials 2005; 26: 2603-10.
108. [108] Oliva AA Jr, James CD, Kingman CE, et al. Patterning axonal guidance molecules using a novel strategy for microcontact printing. Neurochem Res 2003; 28: 1639-48.
109. [109] Huang NF, Patel S, Thakar RG, et al. Myotube assembly on nan-ofibrous and micropatterned polymers. Nano Lett 2006; 6: 537-42.
110. [110] Schachinger V, Assmus B, Britten MB, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the top care AMI Trial. J Am Coll Cardiol 2004; 44(8): 1690-9.
111. [111] Sanganalmath SK, Bolli R. Cell therapy for heart failure: a comprehensive overview of experimental clinical studies, current challenges, and future directions. Circ Res 2013; 113(6): 810-34.
112. [112] Moraes L, Vasconcelos-dos-Santos A, Santana FC, MA, et al. Neuroprotective effects and magnetic resonanceof mesenchymal stem cells labeled with SPION in a rat model of Huntington’s disease. Stem Cell Res 2012; 9(2): 143-55.
113. [113] Molday RS, MacKenzie D. Immunospecific ferromagnetic iron-dextran reagents for the labeling magnetic separation of cells. J Immunol Methods 1982; 52(3): 353-67.
114. [114] Babic M, Horak D, Trchova M, et al. Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling. Bioconjug 2008; 19(3): 740-50.
115. [115] Arbab AS, Bashaw LA, Miller BR, et al. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantation 2003; 76(7): 1123-30.
116. [116] Jasmin, Torres AL, Jelicks L, et al. Labeling stem cells with super-paramagnetic iron oxide nanoparticles: analysis of the labeling effi cacy by microscopy and resonance imaging. Methods Mol Biol 2012; 906: 239-52.
117. [117] Soster M, Juris R, Bonacchi S, et al. Targeted dual-color silica nanoparticles provide univocal identifcation of micrometastases in preclinical models of colorectal cancer. Int J Nanomedicine 2012; 7: 4797-807.
118. [118] Cananzi M, Atala A, De Coppi P. Stem cells derived from amniotic fluid: new potentials in regenerative medicine. Reprod Biomed 2009; Online 18 (Suppl 1): 17-27.
119. [119] Di Corato R, Gazeau F, Le Visage C, et al. High-resolution cellular MRI: gadolinium and iron oxide nanoparticles for in-depth dual-cell imaging of engineered tissue constructs. ACS Nano 2013; 7(9): 7500-12.
120. [120] Park TG, Jeong JH, King SW. Current status of polymeric gene delivery systems. Adv Drug Del Reviews 2006; 58: 467-86.
121. [121] Robinet E, Fehse B, Ebeling S, et al. Improving theex-vivo retrovi-ral-mediated suicide-gene transfer process in T lymphocytes to preserve immune function. Cytotherapy 2005; 7(2): 150-7.
122. [122] Sgodda M, Aurich H, Kleist S, et al. Hepatocyte differentiation of mesenchymal stem cells from rat peritoneal adipose tissue in vitro and in vivo. Exp Cell Res 2007; 313(13): 2875-86.
123. [123] Rock DL, Fraser NW. Detection of HSV-1 genome in central nervous system of latently infected mice. Nature 1983; 302(5908): 523-5.
124. [124] Vicario I, Schimmang T. Transfer of FGF-2 via HSV-1-based amplicon vectors promotes efficient formation of neurons from embryonic stem cells. J Neurosci Methods 2003; 123(1): 55-60.
125. [125] Ikeda N, Nonoguchi N, Zhao MZ, et al. Bone marrow stromal cells that enhanced fibroblast growth factor-2 secretion by herpes simplex virus vector improve neurological outcome after transient focal cerebral ischemia in rats. Stroke 2005; 36(12): 2725-30.
126. [126] Gao F, He T, Wang H, et al. A promising strategy for the treatment of ischemic heart disease. Mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats. Can J Cardiol 2007; 23(11): 891-8.
127. [127] Stender S, Murphy M, T O'Brien, Stengaard C, et al. Adeno-associated vector transduction of human mesenchymal stem cells. Eur Cell Mater 2007; 31(13): 93-9.
128. [128] Felgner PL, Gadek TR, Holm M. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 1987; 84: 7413-7.
129. [129] Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965; 13(1): 238-52.
130. [130] Guo CA, Liu XG, Huo JZ, et al. Chen. Novel gene-modified-tissue engineering of cartilage using stable transforming growth factor-beta1-transfected mesenchymal stem cells grown on chitosan scaffolds. J Biosci Bioeng 2007; 103: 547-56.
131. [131] Jo J, Nagaya N, Miyahara Y, Kataoka M, et al. Transplantation of genetically engineered mesenchymal stem cells improves cardiac function in rats with myocardial infarction: benefit of a novel non-viral vector, cationized dextran. Tissue Eng 2007; 13(2): 313-22.
132. [132] Harrison BS, Atala A. Carbon nanotube applications for tissue engineering. Biomaterials 2007; 28(2): 344-53.
133. [133] Nho Y, Kim JY, Khang D, et al. Adsorption of mesenchymal stem cells and cortical neural stem cells on carbon nano-tube/polycarbonate urethane. Nanomedicine (Lond) 2010; 5(3): 409-17.
134. [134] Kim JY, Khang D, Lee JE, Webster TJ. Decreased macrophage density on carbon nanotube patterns on polycarbonate urethane. J Biomed Mater Res A 2009; 88(2): 419-26.
135. [135] Lee JE, Khang D, Webster TJ. Stem cell impregnated carbon nano-tubes nanofibers for healing damaged neural tissue. Mater Res Soc Symp Proc 2006; 915: R01-R07.
136. [136] Moon SU, Kim J, Bokara KK, et al. Carbon nanotubes impregnated with subventricular zone neural progenitor cells promotes recovery from stroke. Int J Nanomedicine 2012; 7: 2751-65.
137. [137] Bokara KK, Kim JY, Lee YI, Yun K, Webster TJ, Lee JE. Bio-compatibility of carbon nanotubes with stem cells to treat CNS injuries. Ana Cell Biol 2013; 46(2): 85-92.